Opsens Inc. (TSE:OPS – Get Rating) – Equities researchers at Raymond James dropped their FY2026 earnings estimates for Opsens in a note issued to investors on Thursday, July 14th. Raymond James analyst R. Sarugaser now anticipates that the company will post earnings of $0.09 per share for the year, down from their previous forecast of $0.10. The consensus estimate for Opsens' current full-year earnings is ($0.06) per share.

Separately, Stifel Nicolaus began coverage on shares of Opsens in a research note on Wednesday, April 13th. They set a "buy" rating and a C$3.35 price objective for the company.

Opsens Stock Performance

About Opsens

(Get Rating)

Opsens Inc develops, manufactures, installs, and sells fiber optic sensors for interventional cardiology, fractional flow reserve (FFR), oil and gas, and industrial applications. The company operates in two segments, Medical and Industrial. The Medical segment primarily focuses on physiological measurement, such as FFR and dPR in the coronary artery stenosis market; and supplies a range of miniature optical sensors to measure pressure and temperature used in integrated applications in other medical devices, as well as licenses its optical sensor technology.

Featured Stories

• Is There Finally Green Ahead for These 2 Cannabis Leaders?
• Ford Races Higher: Has The Stock Finally Bottomed?
• A Dose of AbbVie Stock Can Help Your Bear Market Portfolio
• PayPal Stock is Attempting to Put in the Floor
• These Consumer Stocks Will Thrive And Here's Why

Receive News & Ratings for Opsens Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Opsens and related companies with MarketBeat.com's FREE daily email newsletter.